In conclusion, the collective findings following METTL13 knockdown in HSPCs and T-ALL cells suggest that METTL13 may be involved in promoting pre-leukemic development of HSPCs and in the pathogenesis of T-ALL. Here, METTL13 is linked to acute lymphoblastic leukemia.